GSK Can't Get High Court Review In Avandia Marketing Fight

By Mike Curley
October 5, 2020, 5:17 PM EDT

The U.S. Supreme Court will not take up an appeal by GlaxoSmithKline in its bid to overturn a Third Circuit decision forcing it to face a suit over the marketing of...

Already a subscriber? Click here to view full article